×
About 80 results

High rate of BA.1, BA.1.1 and BA.2 infection in triple vaccinated
https://www.medrxiv.org/content/10.1101/2022.04.02.22273333v1
Medrxiv Marking U, .

Apr 3rd, 2022 - Background Booster vaccine doses offer protection against severe COVID-19 caused by omicron but are less effective against infection. Characteristics such as serological correlates of protection, viral abundance and clearance of omicron infections in triple vaccinated individuals are scarce.

Is Omicron the end of pandemic or start of a new innings?
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9033632
Travel Medicine and Infectious Disease; Das S, Samanta S et. al.

Apr 27th, 2022 - In the middle of November 2021, Omicron (B.1.1.529), a novel variant of SARS-CoV-2 was identified in South Africa. Owing to continuous increasing cases with rapid transmissibility and immune evasion, the World Health Organization (WHO) has categorized this strain as a variant of concern (VOC). In total, over 60 mutations have been identified in O...

Evusheld - azd7442 kit-AstraZeneca Pharmaceuticals LP
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=168dad7e-9b75-4780-8c8c-34e164de0733

Jun 29th, 2022 - SPL UNCLASSIFIED SECTION HIGHLIGHTS OF EMERGENCY USE AUTHORIZATION (EUA) These highlights of the EUA do not include all the information needed to use EVUSHELD™ under the EUA. See the FULL FACT SHEET FOR HEALTHCARE PROVIDERS for EVUSHELD. EVUSHELD (tixagevimab) injection; (cilgavimab) injection, co-packaged for intramuscular use Original EUA Authorized Date: 12/2021 -----------RECENT MAJOR CHANG...

Prevention of Varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5604a1.htm

Jun 28th, 2022 - Please note: An update has been published for this report. To view update, please click here. Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. Type 508 Accommodation and the title of the report in the subject line of e-mail. Prepared by Mona Marin, MD, Dalya Güris, MD,* Sandra S. Chaves, MD, Scot...

Sexually Transmitted Diseases Treatment Guidelines, 2015
https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6403a1.htm

Jun 29th, 2022 -  Sexually Transmitted Diseases Treatment Guidelines, 2015 Skip directly to search Skip directly to A to Z list Skip directly to site content CDC Home CDC 24/7: Saving Lives. Protecting People.™ Search The CDC Note: Javascript is disabled or is not supported by your browser. For this reason, some items on this page will be unavailable. For more information about this message, please visit this ...

Lagevrio - molnupiravir capsule-Merck Sharp & Dohme LLC
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1b0da643-ab23-4a0b-a9ec-a434522446d0

Aug 26th, 2022 - SPL UNCLASSIFIED SECTION FACT SHEET FOR HEALTHCARE PROVIDERS: EMERGENCY USE AUTHORIZATION FOR LAGEVRIO™ (molnupiravir) CAPSULES HIGHLIGHTS OF EMERGENCY USE AUTHORIZATION (EUA) These highlights of the EUA do not include all the information needed to use LAGEVRIO under the EUA. See the FULL FACT SHEET FOR HEALTHCARE PROVIDERS for LAGEVRIO. LAGEVRIO™ (molnupiravir) capsules, for oral use Original ...

Preventing Tetanus, Diphtheria, and Pertussis Among Adults: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Recommendations of the Advisory Committee on Immunizatio...
https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5517a1.htm

Jun 29th, 2022 - Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. Type 508 Accommodation and the title of the report in the subject line of e-mail. Prepared by Katrina Kretsinger, MD,1,6 Karen R. Broder, MD,1,6 Margaret M. Cortese, MD,2,6 M. Patricia Joyce, MD, 1 Ismael Ortega-Sanchez, PhD,2 Grace M. Lee, MD,3 Te...

The Role of Anti-PD-L1 Immunotherapy in Cancer
https://www.onclive.com/view/the-role-of-anti-pd-l1-immunotherapy-in-cancer

Dec 4th, 2020 - Immunotherapy has become an increasingly appealing therapeutic strategy for patients with cancer, with many late-stage clinical trials demonstrating overall survival (OS) advantages in melanoma and castrationresistant prostate cancer. More recently, non-small cell lung cancer (NSCLC) has become a focus for the next generation of immune-based therapeutic strategies. Immunotherapy, in particular ...

COVID-19 Recurrence After Paxlovid Treatment Not Likely Due to Resistance, Impaired Immunity
https://www.infectiousdiseaseadvisor.com/home/topics/covid19/recurrent-covid-19-causes-after-paxlovid-treatment/
Infectious Disease Advisor

Jul 20th, 2022 - Neither treatment resistance nor a lack of neutralizing immunity were likely causes of recurrent COVID-19 infection in a patient who had received treatment with Paxlovid™ (nirmatrelvir/ritonavir), according to findings published in Clinical Infectious Diseases. Investigators at the University of California, San Diego, evaluated humoral immunity and potential drug resistance in a patient ...

Moderna covid-19 vaccine, bivalent - moderna covid-19 vaccine, bivalent injection, suspension-Moderna US, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=dc9e86ab-f023-40f8-9b61-d9039bdcea1d

Jul 28th, 2022 - SPL UNCLASSIFIED SECTION MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5) BOOSTER DOSE FOR 18 YEARS OF AGE AND OLDER The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) to permit the emergency use of the unapproved product, Moderna COVID-19 Vaccine, Bivalent (Original and Omicron BA.4/BA.5), for active immunization to prevent COVID-19 i...

2022 EIS Conference Media Resources | Attending EIS Conference | Epidemic Intelligence Service | CDC
https://www.cdc.gov/eis/conference/at-a-glance/media-resources.html

Jun 28th, 2022 - Tick-Borne Relapsing Fever Surveillance Practices — Western United States, 2021 Amy Beeson, MD, AB Presentation Day/Time: Thursday, May 5, 2:30 pm – 2:50 pm Tick-borne relapsing fever (TBRF) is a rare illness caused by Borrelia spirochetes and characterized by relapsing episodes of high fever, headache, and myalgia. Without prompt effective antibiotics, severe disease or death can occur...

Science Clips - Volume 13, Issue 35, September 28, 2021
https://www.cdc.gov/library/sciclips/issues/v13issue35.html

Jun 28th, 2022 - Science Clips is produced weekly to enhance awareness of emerging scientific knowledge for the public health community. Each article features an Altmetric Attention score to track social and mainstream media mentions. The report consists of these components: Top Articles of the Week. CDC-authored publications. Top Articles of the Week Selected weekly by a senior CDC scientist from the standard ...

Moderna covid-19 vaccine - cx-024414 injection, suspension-Moderna US, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e0651c7a-2fe2-459d-a766-0d59e919f058

Sep 9th, 2022 - SPL UNCLASSIFIED SECTION PRIMARY SERIES For 12 Years and Older   The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) to permit the emergency use of the unapproved product, MODERNA COVID-19 VACCINE, for active immunization to prevent COVID-19 in individuals 6 months of age and older. This Fact Sheet pertains only to Moderna COVID-19 Vaccine supplied in a ...

Sotrovimab - sotrovimab injection, solution, concentrate-GlaxoSmithKline LLC
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aa5cca2e-4351-4f81-b0e5-3303ac0b2474

Feb 23rd, 2022 - SPL UNCLASSIFIED SECTION The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) to permit the emergency use of the unapproved product sotrovimab for the treatment of mild-to-moderate coronavirus disease 2019 (COVID-19) in adults and pediatric patients (12 years of age and older weighing at least 40 kg) with positive results of direct SARS-CoV-2 viral testing...

Etesevimab - etesevimab injection, solution-Eli Lilly and Company
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aacdd8a7-18b7-43c6-b866-14aa491a0c15

Jan 24th, 2022 - SPL UNCLASSIFIED SECTION TREATMENT The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) to permit the emergency use of the unapproved products bamlanivimab and etesevimab administered together for the treatment of mild to moderate coronavirus disease 2019 (COVID-19) in adults and pediatric patients, including neonates, with positive results of direct SARS-...

Bamlanivimab - bamlanivimab injection, solution-Eli Lilly and Company
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c7e9d8a6-e8c2-4681-9362-51d5bdbae00d

Dec 22nd, 2021 - SPL UNCLASSIFIED SECTION TREATMENT The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) to permit the emergency use of the unapproved products bamlanivimab and etesevimab administered together for the treatment of mild to moderate coronavirus disease 2019 (COVID-19) in adults and pediatric patients, including neonates, with positive results of direct SARS-...

Science Clips - Volume 11, Issue 24 June 18, 2019
https://www.cdc.gov/library/sciclips/issues/v11issue24.html

Jun 28th, 2022 - Public Health Grand Rounds. Science Clips is produced weekly to enhance awareness of emerging scientific knowledge for the public health community. Each article features an Altmetric Attention score to track social and mainstream media mentions! The report consists of these components: Key scientific articles in featured topic areas (this week featuring June CDC Public Health Grand Rounds: Mate...

Science Clips - Volume 11, Issue 47 November 26, 2019
https://www.cdc.gov/library/sciclips/issues/v11issue47.html

Jun 28th, 2022 - Science Clips is produced weekly to enhance awareness of emerging scientific knowledge for the public health community. Each article features an Altmetric Attention score to track social and mainstream media mentions! The report consists of these components: Top Articles of the Week. CDC-authored publications. Top Articles of the Week Selected weekly by a senior CDC scientist from the standard ...

Science Clips - Volume 9, Issue 22, June 6, 2017
https://www.cdc.gov/library/sciclips/issues/v9issue22.html

Jun 28th, 2022 - Science Clips is produced weekly to enhance awareness of emerging scientific knowledge for the public health community. Each article features an Altmetric Attention score to track social and mainstream media mentions! This week, Science Clips is pleased to collaborate with CDC Vital Signs by featuring scientific articles from the June Vital Signs (www.cdc.gov/vitalsigns). The articles marked wi...

Science Clips - Volume 9, Issue 15, April 18, 2017
https://www.cdc.gov/library/sciclips/issues/v9issue15.html

Jun 28th, 2022 - Each Tuesday, to enhance awareness of emerging scientific knowledge, selected science clips will be posted here for the public health community. The focus is applied public health research and prevention science that has the capacity to improve health now. The report consists of these components: Key scientific articles in featured topic areas (this week featuring April CDC Public Health Grand ...